Welcome to the LNP Flagship Summit Community

This is the global hub for industry leaders to connect, collaborate, and network with the LNP community under one roof. As the only industry-led forum dedicated to end-to-end LNP discovery, formulation, characterization, process development, and scalable manufacturing, this community brings together 250+ experts to share insights, tackle real-world challenges, and build meaningful connections across the full LNP spectrum.

Pre-Event Opportunities

Networking Session Spotlight

Conference Day One - Morning

9:30 am Panel Discussion: Navigating Strategic Investments by Harnessing Insights from Recent Acquisitions & Collaborations within the LNP Field

  • What are the driving factors behind recent deals, what are the unique aspects of LNP technology that investors are most focused on?
  • What key factors do investors evaluate when assessing the potential and risks of LNP technologies?
  • Beyond individual drug candidates, how do investors envision the broader potential and future impact of these LNP partnerships?
Conference Day One - Afternoon

3:00 pm Afternoon Networking Break & Scientific Poster Session

  • Contribute to the conversation and share your cutting-edge research with your fellow LNP community to showcase your breakthrough discoveries to a vast audience of experts. Register your place to submit an abstract for review to showcase your poster.

Time to Connect

  • Speed networking formats
  • Dedicated hours
  • Roundtables
  • Panels
  • Q&As
  • Attendee Visibility
LNP Formulation & Process Development Summit - Blind Attendee List

Meet the Scientific Experts

The Scientific Advisory Board of the 5th LNP Formulation & Process Development Summit brings together world-renowned experts whose leadership and insight ensure a program of unparalleled depth, relevance, and scientific excellence to accelerate LNP innovation.

The 2026 board includes Annette Bak, Head of Advanced Drug Delivery (ADD) at AstraZeneca, Luis Brito, Vice President of Delivery Platform at Beam Therapeutics, and Ching Kim Tye, Head of Drug Product Platform and Early Clinical Development at Sanofi.

Don’t just take our word for it…

Novo Nordisk

An excellent opportunity to participate with experts of all types in the LNP field!

Scientist II, Nucleic Acid Delivery, Novo Nordisk